{"count": 11, "results": [{"_id": "35784377", "pmid": 35784377, "pmcid": "PMC9240956", "title": "Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study", "journal": "JPRAS Open", "authors": ["Wilson S", "Hassan D", "Jakeman M", "Breuning E"], "date": "2022-05-26T00:00:00Z", "doi": "10.1016/j.jpra.2022.05.010", "meta_date_publication": "2022 Sep", "meta_volume": "33", "meta_issue": "", "meta_pages": "52-56", "score": 50312.87, "text_hl": "...Of the five @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ @SPECIES_9606 @@@patients@@@ identified, two had single @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@IH@@@ and three had multiple @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@IH@@@ that resulted in a total of nine individual lesions treated with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@. ", "citations": {"NLM": "Wilson S, Hassan D, Jakeman M, Breuning E. Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study JPRAS Open. 2022 Sep;33():52-56. PMID: 35784377", "BibTeX": "@article{35784377, title={Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study}, author={Wilson S and Hassan D and Jakeman M and Breuning E}, journal={JPRAS Open}, volume={33}, pages={52-56}}"}}, {"_id": "37275818", "pmid": 37275818, "pmcid": "PMC10238967", "title": "Comparing the Effectiveness of Propranolol versus Atenolol in Inducing Clinical Clearance in the Treatment of Infantile Haemangioma: A Randomised Controlled Trial", "journal": "Indian J Dermatol", "authors": ["Ashraf R", "Mahajan R", "Malik MA", "Handa S", "Sinha A", "De D", "Sachdeva N"], "date": "2023-03-01T00:00:00Z", "doi": "10.4103/ijd.ijd_867_22", "meta_date_publication": "2023 Mar-Apr", "meta_volume": "68", "meta_issue": "2", "meta_pages": "148-155", "score": 50300.86, "text_hl": "Comparing the Effectiveness of @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@Propranolol@@@ versus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ in Inducing Clinical Clearance in the Treatment of @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@Infantile Haemangioma@@@: A Randomised Controlled Trial", "citations": {"NLM": "Ashraf R, Mahajan R, Malik MA, Handa S, Sinha A, De D, Sachdeva N. Comparing the Effectiveness of Propranolol versus Atenolol in Inducing Clinical Clearance in the Treatment of Infantile Haemangioma: A Randomised Controlled Trial Indian J Dermatol. 2023 Mar-Apr;68(2):148-155. PMID: 37275818", "BibTeX": "@article{37275818, title={Comparing the Effectiveness of Propranolol versus Atenolol in Inducing Clinical Clearance in the Treatment of Infantile Haemangioma: A Randomised Controlled Trial}, author={Ashraf R and Mahajan R and Malik MA and Handa S and Sinha A and De D and Sachdeva N}, journal={Indian J Dermatol}, volume={68}, number={2}, pages={148-155}}"}}, {"_id": "35506358", "pmid": 35506358, "pmcid": "PMC9677271", "title": "Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma", "journal": "Acta Derm Venereol", "authors": ["Hermans MM", "Breugem CC", "Schappin R", "Jonge Poerink E", "Mendels EJ", "Ragamin A", "Breur JMPJ", "Langeveld HR", "Raphael MF", "De Laat PCJ", "De Wildt SN", "Rietman AB", "Pasmans SGMA", "De Graaf M"], "date": "2022-10-11T00:00:00Z", "doi": "10.2340/actadv.v102.2021", "meta_date_publication": "2022 Oct 11", "meta_volume": "102", "meta_issue": "", "meta_pages": "adv00788", "score": 50285.94, "text_hl": "Aesthetic Outcome of @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@Propranolol@@@ vs @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ Treatment of Children with @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@Infantile Haemangioma@@@", "citations": {"NLM": "Hermans MM, Breugem CC, Schappin R, Jonge Poerink E, Mendels EJ, Ragamin A, Breur JMPJ, Langeveld HR, Raphael MF, De Laat PCJ, De Wildt SN, Rietman AB, Pasmans SGMA, De Graaf M. Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma Acta Derm Venereol. 2022 Oct 11;102():adv00788. PMID: 35506358", "BibTeX": "@article{35506358, title={Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma}, author={Hermans MM and Breugem CC and Schappin R and Jonge Poerink E and Mendels EJ and Ragamin A and Breur JMPJ and Langeveld HR and Raphael MF and De Laat PCJ and De Wildt SN and Rietman AB and Pasmans SGMA and De Graaf M}, journal={Acta Derm Venereol}, volume={102}, pages={adv00788}}"}}, {"_id": "39365598", "pmid": 39365598, "title": "Efficacy and safety of atenolol versus propranolol for treatment of infantile haemangioma: A narrative review.", "journal": "Clin Exp Dermatol", "authors": ["Shi M", "Wargon O", "Tatian A"], "date": "2024-10-04T00:00:00Z", "doi": "10.1093/ced/llae401", "meta_date_publication": "2024 Oct 4", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50284.965, "text_hl": "Efficacy and safety of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ versus @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ for treatment of @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@infantile haemangioma@@@: A narrative review.", "citations": {"NLM": "Shi M, Wargon O, Tatian A. Efficacy and safety of atenolol versus propranolol for treatment of infantile haemangioma: A narrative review. Clin Exp Dermatol. 2024 Oct 4;():. PMID: 39365598", "BibTeX": "@article{39365598, title={Efficacy and safety of atenolol versus propranolol for treatment of infantile haemangioma: A narrative review.}, author={Shi M and Wargon O and Tatian A}, journal={Clin Exp Dermatol}}"}}, {"_id": "32742396", "pmid": 32742396, "pmcid": "PMC7388287", "title": "Atenolol vs. propranolol for the treatment of infantile haemangiomas: A systematic review and meta-analysis", "journal": "Exp Ther Med", "authors": ["Liu Z", "Wu C", "Song D", "Wang L", "Li J", "Wang C", "Guo L"], "date": "2020-08-01T00:00:00Z", "doi": "10.3892/etm.2020.8842", "meta_date_publication": "2020 Aug", "meta_volume": "20", "meta_issue": "2", "meta_pages": "1644-1652", "score": 50283.12, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ vs. @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ for the treatment of @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@infantile haemangiomas@@@: A systematic review and meta-analysis", "citations": {"NLM": "Liu Z, Wu C, Song D, Wang L, Li J, Wang C, Guo L. Atenolol vs. propranolol for the treatment of infantile haemangiomas: A systematic review and meta-analysis Exp Ther Med. 2020 Aug;20(2):1644-1652. PMID: 32742396", "BibTeX": "@article{32742396, title={Atenolol vs. propranolol for the treatment of infantile haemangiomas: A systematic review and meta-analysis}, author={Liu Z and Wu C and Song D and Wang L and Li J and Wang C and Guo L}, journal={Exp Ther Med}, volume={20}, number={2}, pages={1644-1652}}"}}, {"_id": "37649330", "pmid": 37649330, "pmcid": "PMC10506515", "title": "Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers", "journal": "Acta Derm Venereol", "authors": ["Hermans MM", "Pasmans SGMA", "De Graaf M", "Ragamin A", "Mendels EJ", "Breur JMPJ", "Langeveld HR", "Raphael MF", "De Laat PCJ", "De Wildt SN", "Rietman AB", "Breugem CC", "Schappin R"], "date": "2023-08-30T00:00:00Z", "doi": "10.2340/actadv.v103.5286", "meta_date_publication": "2023 Aug 30", "meta_volume": "103", "meta_issue": "", "meta_pages": "adv5286", "score": 50265.105, "text_hl": "These results, based on multivariable analyses of @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@IH@@@ treated with either @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ or @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, are substantiated by results of previous studies using univariable analyses of untreated @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@IH@@@ and @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@IH@@@ treated with @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@. ", "citations": {"NLM": "Hermans MM, Pasmans SGMA, De Graaf M, Ragamin A, Mendels EJ, Breur JMPJ, Langeveld HR, Raphael MF, De Laat PCJ, De Wildt SN, Rietman AB, Breugem CC, Schappin R. Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers Acta Derm Venereol. 2023 Aug 30;103():adv5286. PMID: 37649330", "BibTeX": "@article{37649330, title={Prognostic Factors for Long-term Aesthetic Outcome of Infantile Haemangioma Treated with Beta-blockers}, author={Hermans MM and Pasmans SGMA and De Graaf M and Ragamin A and Mendels EJ and Breur JMPJ and Langeveld HR and Raphael MF and De Laat PCJ and De Wildt SN and Rietman AB and Breugem CC and Schappin R}, journal={Acta Derm Venereol}, volume={103}, pages={adv5286}}"}}, {"_id": "28112790", "pmid": 28112790, "title": "Atenolol treatment for infantile haemangioma.", "journal": "Br J Dermatol", "authors": ["Tasani M", "Glover M", "Martinez AE", "Shaw L"], "date": "2017-05-01T00:00:00Z", "doi": "10.1111/bjd.15317", "meta_date_publication": "2017 May", "meta_volume": "176", "meta_issue": "5", "meta_pages": "1400-1402", "score": 50107.707, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ treatment for @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@infantile haemangioma@@@.", "citations": {"NLM": "Tasani M, Glover M, Martinez AE, Shaw L. Atenolol treatment for infantile haemangioma. Br J Dermatol. 2017 May;176(5):1400-1402. PMID: 28112790", "BibTeX": "@article{28112790, title={Atenolol treatment for infantile haemangioma.}, author={Tasani M and Glover M and Martinez AE and Shaw L}, journal={Br J Dermatol}, volume={176}, number={5}, pages={1400-1402}}"}}, {"_id": "30515761", "pmid": 30515761, "title": "Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review.", "journal": "Australas J Dermatol", "authors": ["Wang Q", "Xiang B", "Chen S", "Ji Y"], "date": "2019-08-01T00:00:00Z", "doi": "10.1111/ajd.12966", "meta_date_publication": "2019 Aug", "meta_volume": "60", "meta_issue": "3", "meta_pages": "181-185", "score": 50090.14, "text_hl": "Efficacy and safety of oral @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ for the treatment of @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@infantile haemangioma@@@: A systematic review.", "citations": {"NLM": "Wang Q, Xiang B, Chen S, Ji Y. Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review. Australas J Dermatol. 2019 Aug;60(3):181-185. PMID: 30515761", "BibTeX": "@article{30515761, title={Efficacy and safety of oral atenolol for the treatment of infantile haemangioma: A systematic review.}, author={Wang Q and Xiang B and Chen S and Ji Y}, journal={Australas J Dermatol}, volume={60}, number={3}, pages={181-185}}"}}, {"_id": "24011909", "pmid": 24011909, "title": "Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.", "journal": "J Plast Reconstr Aesthet Surg", "authors": ["de Graaf M", "Raphael MF", "Breugem CC", "Knol MJ", "Bruijnzeel-Koomen CA", "Kon M", "Breur JM", "Pasmans SG"], "date": "2013-12-01T00:00:00Z", "doi": "10.1016/j.bjps.2013.07.035", "meta_date_publication": "2013 Dec", "meta_volume": "66", "meta_issue": "12", "meta_pages": "1732-40", "score": 50088.34, "text_hl": "This study indicates that @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ is effective in the treatment of @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@IH@@@. ", "citations": {"NLM": "de Graaf M, Raphael MF, Breugem CC, Knol MJ, Bruijnzeel-Koomen CA, Kon M, Breur JM, Pasmans SG. Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group. J Plast Reconstr Aesthet Surg. 2013 Dec;66(12):1732-40. PMID: 24011909", "BibTeX": "@article{24011909, title={Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.}, author={de Graaf M and Raphael MF and Breugem CC and Knol MJ and Bruijnzeel-Koomen CA and Kon M and Breur JM and Pasmans SG}, journal={J Plast Reconstr Aesthet Surg}, volume={66}, number={12}, pages={1732-40}}"}}, {"_id": "24200706", "pmid": 24200706, "title": "Reply to 'Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.'.", "journal": "J Plast Reconstr Aesthet Surg", "authors": ["Raju A", "Khundkar R"], "date": "2014-03-01T00:00:00Z", "doi": "10.1016/j.bjps.2013.10.025", "meta_date_publication": "2014 Mar", "meta_volume": "67", "meta_issue": "3", "meta_pages": "412-3", "score": 50085.55, "text_hl": "Reply to 'Treatment of @<m>DISEASE_271245</m> @DISEASE_OMIM:271245 @@@infantile haemangiomas@@@ with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@: comparison with a historical @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ group.'.", "citations": {"NLM": "Raju A, Khundkar R. Reply to 'Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.'. J Plast Reconstr Aesthet Surg. 2014 Mar;67(3):412-3. PMID: 24200706", "BibTeX": "@article{24200706, title={Reply to 'Treatment of infantile haemangiomas with atenolol: comparison with a historical propranolol group.'.}, author={Raju A and Khundkar R}, journal={J Plast Reconstr Aesthet Surg}, volume={67}, number={3}, pages={412-3}}"}}]}